Deep vein thrombosis / Peripheral arterial occlusive disease (PAOD) – F5 gene analysis (Leiden mutation), F2 gene analysis (G20210A mutation), MTHFR gene analysis – panel
Analysis ID 197
Analysis location “GENESIS” Centre for Medical Genetics
Diagnosed illness Deep vein thrombosis / Peripheral arterial occlusive disease (PAOD) – F5 gene analysis (Leiden mutation), F2 gene analysis (G20210A mutation), MTHFR gene analysis – panel
OMIM #188050
Clinical information Thrombophilia is a multifactorial disorder of abnormal blood clot formation resulting from an interaction of genetic, acquired, and environmental predisposing factors. Venous thromboembolism most commonly manifests as deep vein thrombosis, which may result in a pulmonary embolism, once the clot gets into the blood vessels of the lungs. Other manifestations include thrombosis of the cerebral or visceral veins, as well as recurrent pregnancy loss.
Type of analysis Molecular
Type of biological material 5 ml of peripheral blood collected in an ETDA tube; DNA sample
Analyzed genes MTHFR; F2; F5
Analysis description Analysis consists of F5 gene testing for Leiden mutation, F2 gene testing for G20210A mutation, and MTHFR gene testing for the 2 most common mutations
Analysis indication Symptoms of deep vein thrombosis / peripheral arterial occlusive disease (PAOD)
Analysis time 3 - 4 weeks
Refund Yes
CGM laboratory name Laboratory for Molecular Genetics